Éric Asselin

11.7k total citations
107 papers, 4.7k citations indexed

About

Éric Asselin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Éric Asselin has authored 107 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 29 papers in Oncology and 28 papers in Genetics. Recurrent topics in Éric Asselin's work include Estrogen and related hormone effects (28 papers), Reproductive System and Pregnancy (23 papers) and Metal complexes synthesis and properties (17 papers). Éric Asselin is often cited by papers focused on Estrogen and related hormone effects (28 papers), Reproductive System and Pregnancy (23 papers) and Metal complexes synthesis and properties (17 papers). Éric Asselin collaborates with scholars based in Canada, United States and France. Éric Asselin's co-authors include Sophie Parent, Parvesh Chaudhry, Valérie Leblanc, Michel A. Fortier, Benjamin K. Tsang, Gervais Bérubé, Céline Van Themsche, Gordon B. Mills, Kevin Brasseur and Véronique Gagnon and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Éric Asselin

104 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Asselin Canada 40 2.3k 1.1k 1.1k 658 637 107 4.7k
Sanjoy K. Das United States 42 2.0k 0.9× 287 0.3× 3.3k 3.0× 1.2k 1.8× 2.3k 3.6× 94 6.5k
Yukihiro Nishio Japan 30 2.7k 1.2× 1.9k 1.6× 1.9k 1.7× 826 1.3× 355 0.6× 60 6.3k
Doris M. Benbrook United States 38 3.4k 1.5× 988 0.9× 794 0.7× 1.0k 1.5× 357 0.6× 144 5.2k
Grazia Graziani Italy 43 3.6k 1.6× 2.6k 2.3× 890 0.8× 279 0.4× 164 0.3× 197 6.3k
Jack‐Michel Renoir France 39 2.9k 1.3× 861 0.8× 570 0.5× 1.3k 1.9× 235 0.4× 84 5.0k
Tao Yi China 36 1.9k 0.8× 673 0.6× 868 0.8× 181 0.3× 316 0.5× 206 4.1k
Jeehyeon Bae South Korea 32 1.9k 0.8× 240 0.2× 289 0.3× 596 0.9× 312 0.5× 106 3.2k
Peter T. Daniel Germany 53 5.2k 2.3× 2.8k 2.4× 1.8k 1.7× 401 0.6× 70 0.1× 135 8.2k
Ajoy Basak Canada 38 2.4k 1.0× 811 0.7× 492 0.4× 343 0.5× 257 0.4× 116 5.6k
Alfonso Calvo Spain 40 2.4k 1.1× 1.5k 1.3× 539 0.5× 281 0.4× 248 0.4× 198 5.0k

Countries citing papers authored by Éric Asselin

Since Specialization
Citations

This map shows the geographic impact of Éric Asselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Asselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Asselin more than expected).

Fields of papers citing papers by Éric Asselin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Asselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Asselin. The network helps show where Éric Asselin may publish in the future.

Co-authorship network of co-authors of Éric Asselin

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Asselin. A scholar is included among the top collaborators of Éric Asselin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Asselin. Éric Asselin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yulei, Taha Azad, Elizabeth D. Lightbody, et al.. (2018). PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular Cancer Research. 16(6). 1046–1058. 56 indexed citations
2.
Adam, Pascal, et al.. (2018). Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death. Cell Communication and Signaling. 16(1). 39–39. 5 indexed citations
3.
Brasseur, Kevin, et al.. (2013). Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium1. Biology of Reproduction. 88(3). 79–79. 25 indexed citations
4.
Gagnon, Véronique, et al.. (2013). Liver Glucagon Receptors (GluR): Effect of Exercise and Fasting on Binding Characteristics, GluR-mRNA, and GluR Protein Content in Rats. Hormone and Metabolic Research. 45(10). 716–721. 8 indexed citations
5.
Fortier, Anne-Marie, Éric Asselin, & Monique Cadrin. (2011). Functional specificity of Akt isoforms in cancer progression. BioMolecular Concepts. 2(1-2). 1–11. 26 indexed citations
6.
Chaudhry, Parvesh, et al.. (2010). Transforming Growth Factor Beta Regulates Proliferation and Invasion of Rat Placental Cell Lines1. Biology of Reproduction. 84(3). 553–559. 43 indexed citations
7.
Gupta, Atul, et al.. (2010). Design, synthesis and biological evaluation of estradiol–chlorambucil hybrids as anticancer agents. Bioorganic & Medicinal Chemistry Letters. 20(5). 1614–1618. 48 indexed citations
8.
Froehlich, E., Atul Gupta, Éric Asselin, et al.. (2008). Study of DNA Interactions with Steroidal and Nonsteroidal Estrogen–Platinum (II)–Based Anticancer Drugs. DNA and Cell Biology. 28(1). 31–39. 20 indexed citations
9.
N’soukpoé-Kossi, Christophe N., Caroline Descôteaux, Éric Asselin, et al.. (2008). Transfer RNA Bindings to Antitumor Estradiol-Platinum(II) Hybrid and Cisplatin. DNA and Cell Biology. 27(6). 337–343. 25 indexed citations
10.
Barman, Soma, Gervais Bérubé, Éric Asselin, et al.. (2007). A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 17(17). 4955–4960. 25 indexed citations
11.
N’soukpoé-Kossi, Christophe N., Caroline Descôteaux, Éric Asselin, Heidar‐Ali Tajmir‐Riahi, & Gervais Bérubé. (2007). DNA Interaction with Novel Antitumor Estradiol–Platinum(II) Hybrid Molecule: A Comparative Study with Cisplatin Drug. DNA and Cell Biology. 27(2). 101–107. 71 indexed citations
12.
LeBlanc, Kim, et al.. (2007). Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.. PubMed. 30(2). 477–87. 36 indexed citations
13.
14.
LeBlanc, Kim, et al.. (2005). Uterine cancer cells proliferate differently in response to 17β-estradiol in presence or absence of tamoxifen, raloxifen and ICI 182 780. Cancer Research. 65. 947–947. 1 indexed citations
15.
LeBlanc, Kim, et al.. (2005). Resveratrol mediates cell fate in human uterine cancer cells through prostaglandin inhibition. Cancer Research. 65. 177–177. 1 indexed citations
16.
Leblanc, Valérie, et al.. (2005). TGF-beta expression during rat pregnancy and activity on decidual cell survival. Reproductive Biology and Endocrinology. 3(1). 20–20. 61 indexed citations
17.
Gagnon, Véronique, Caroline Descôteaux, Sophie Parent, et al.. (2004). Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers—molecular modeling studies. Bioorganic & Medicinal Chemistry Letters. 14(23). 5919–5924. 47 indexed citations
18.
Gagnon, Véronique, et al.. (2004). AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecologic Oncology. 94(3). 785–795. 96 indexed citations
19.
Leblanc, Valérie, et al.. (2003). Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17β-estradiol at estrus. Reproductive Biology and Endocrinology. 1(1). 59–59. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjoy K. Das Breakdown of academic impact, for papers by Yukihiro Nishio Breakdown of academic impact, for papers by Doris M. Benbrook Breakdown of academic impact, for papers by Grazia Graziani Breakdown of academic impact, for papers by Jack‐Michel Renoir Breakdown of academic impact, for papers by Tao Yi Breakdown of academic impact, for papers by Jeehyeon Bae Breakdown of academic impact, for papers by Peter T. Daniel Breakdown of academic impact, for papers by Ajoy Basak Breakdown of academic impact, for papers by Alfonso Calvo
Rankless by CCL
2026